Strategic cooperation with Tilman

Strategic cooperation with Tilman

Lavipharm has entered into a cooperation agreement with the Belgian medical plant specialist Tilman in the sector of plant based pharmaceutical products.

Tilman is one of the largest companies in Europe and its plant originated products are marketed in 30 countries around the world. Tilman laboratories, established 50 years ago, are considered to be of the best equipped across Europe. Specializing in formulations based on natural ingredients, Tilman innovates and develops new plant based preparations in many modern forms meeting two main criteria: quality and safety. The company’s production facilities operate under the strictest rules and GMP (Good Manufacturing Practices) standards of the pharmaceutical industry.

Tilman products are now marketed in Greek pharmacies by Lavipharm. As stated by Mr. Telemaque Lavidas: “Phytotherapy represents an emerging and constantly evolving market in the Greek pharmacy channel, leading us to the strategic decision to invest in this promising segment. Moreover, it is important for Lavipharm to always enter into new cooperations with well-established partners, such as Tilman, enhancing its 100 years successful presence in the Greek pharmacies with safe and effective therapeutic solutions.”

Tilman products are addressing conditions such as cold and flu, indigestion, weight loss, pain and joined stiffness, irritated skin. Phytotherapy offers solutions which are both gentle and effective and meet the needs of the modern consumer for health and wellness.

Lavipharm is an integrated Group engaged in the research, development, manufacturing, marketing, sales, wholesaling, distribution, and retailing of pharmaceutical, cosmetic and consumer health products in Greece with a strong international activity.